Immunic, Inc. (IMUX) Q1 2024 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Immunic, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.629 -- 00:00:04.733 Good morning and welcome to Munich's first quarter 2024 earnings call. 00:00:04.733 -- 00:00:08.456 My name is Jessica Bru, Vice President Investor Relations and Communications here at 00:00:08.456 -- 00:00:11.539 eMunich. I will also be the moderator today. 00:00:11.539 -- 00:00:15.823 Speaking on the call are Dr. Daniel Fitt, our Chief Executive Officer and President, 00:00:15.823 -- 00:00:18.786 as well as Glenn Whaley, our Chief Financial Officer. 00:00:18.786 -- 00:00:22.389 Please note that all participants will be in listen-only mode and this event is being 00:00:22.389 -- 00:00:27.492 recorded. After today's presentation, there will be an opportunity to ask questions. 00:00:27.492 -- 00:00:32.073 If you join the webcast via the Zoom platform, there are two ways to submit questions. 00:00:32.073 -- 00:00:36.515 You can either submit your questions in writing via the Q&A tool of the Zoom portal, 00:00:36.515 -- 00:00:40.336 or if you would like to speak with us directly, please use the raise hand function in 00:00:40.336 -- 00:00:43.457 the Zoom portal to queue your question. 00:00:44.468 -- 00:00:49.093 Before we begin, I would like to remind you that this presentation may contain forward-looking 00:00:49.093 -- 00:00:54.619 statements. Such statements can be identified by words such as may, will, expect, anticipate, 00:00:54.619 -- 00:00:56.721 estimate, or words with a similar meaning. 00:00:56.721 -- 00:01:01.126 And such statements involve a number of risks and uncertainties that could cause Immunix's 00:01:01.126 -- 00:01:04.770 actual results to differ materially from those discussed here. 00:01:04.770 -- 00:01:09.332 Please note that these forward-looking statements reflect Immunix opinions 00:01:09.332 -- 00:01:14.11...